Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
37.00    -1.50 (-3.90%)
Bid:
36.94
Ask:
37.00
Spread: 0.06 (0.162%)
Market Cap: £374.70m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Strategy/Company/Ops Update

23 Apr 2020 07:00

RNS Number : 6182K
Aston Martin Lagonda Global Hld PLC
23 April 2020
Β 

23 April 2020

Β 

Aston Martin Lagonda Global Holdings plc

Β 

Planned reopening of production facilities, business protection measures and remuneration

Β 

As we continue to manage the challenges posed by COVID-19, Aston Martin Lagonda's primary concern remains the health and safety of its employees and their families, business partners and the local communities. The Company is committed to providing all the support possible while following public health advice from relevant governments in support of their efforts to contain the spread of the virus.

Β 

Further to the 24 March update on operations, over the past weeks Aston Martin Lagonda has been working closely with employees and trade unions to develop and implement protocols to protect employee health and safety in its production facilities so that they are able to return to work. The Company is now pleased to announce that it intends to reopen its St Athan manufacturing facility on May 5 following Public Health Wales and England guidelines which protect the safety of its people. The Company has also been working closely with its suppliers to secure supply aligned to this timing. Taking the learnings, in terms of health and safety, from reopening St Athan, Gaydon manufacturing operations are planned to resume later.

Β 

As part of previously announced mitigation measures in response to COVID-19, Aston Martin Lagonda commenced the process of furloughing employees and has applied for the financial support offered by the Government's 'Job Retention Scheme'. The majority of the Company's workforce is currently furloughed. Those employees who continue to be furloughed from 1 May will receive 80% of their base salaries from then, with the Company topping up the Government's funding for those whose salaries exceed the maximum support level provided by the Scheme.

Β 

The Company continues to monitor and regularly review the situation whilst working closely with all its stakeholders including employees, trade unions, the Government, public health authorities and local communities to protect the safety of its people, protect jobs, and protect the business.

Β 

Further, senior leadership has agreed to a voluntary reduction in pay. Non-Executive Directors are waiving 35% of their fees and the Chief Executive Officer is waiving 35% of his base salary and, as communicated in the 2019 Annual Report, will not participate in the FY 2020 annual bonus plan. Vice Presidents are waiving 20% of their base salaries. Other members of senior management have also been asked to voluntarily waive 5%-10% of base salary depending on salary level. These changes will be applied retrospectively for a three-month period from 1 April and will be kept under monthly review. In his role as Executive Chairman, Lawrence Stroll has elected to receive a nominal salary only, of Β£1 per annum.

Β 

Β 

Β 

Enquiries

Investors and Analysts

Charlotte Cowley

Director of Investor Relations

+44 (0)7771 976764

charlotte.cowley@astonmartin.com

Media

Kevin Watters

Director of Communications

+44 (0)7764 386683

kevin.watters@astonmartin.com

Toby Bates

Senior Adviser, Financial Communications

+44 (0)7584 773837

toby.bates1@astonmartin.com

Grace Barnie

Corporate Communications Manager

+44 (0)7880 903490

grace.barnie@astonmartin.com

Brunswick

Dan Roberts

+44 (0)20 7404 5959

Diana Vaughton

astonmartin@brunswickgroup.com

Β 

No representations or warranties, express or implied, are made as to, and no reliance should be placed on, the accuracy, fairness or completeness of the information presented or contained in this release. This release contains certain forward-looking statements, which are based on current assumptions and estimates by the management of Aston Martin Lagonda Global Holdings plc ("Aston Martin Lagonda"). Past performance cannot be relied upon as a guide to future performance and should not be taken as a representation that trends or activities underlying past performance will continue in the future. Such statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from any expected future results in forward-looking statements. These risks may include, for example, changes in the global economic situation, and changes affecting individual markets and exchange rates.

Β 

Aston Martin Lagonda provides no guarantee that future development and future results achieved will correspond to the forward-looking statements included here and accepts no liability if they should fail to do so. Aston Martin Lagonda undertakes no obligation to update these forward-looking statements and will not publicly release any revisions that may be made to these forward-looking statements, which may result from events or circumstances arising after the date of this release.

Β 

This release is for informational purposes only and does not constitute or form part of any invitation or inducement to engage in investment activity, nor does it constitute an offer or invitation to buy any securities, in any jurisdiction including the United States, or a recommendation in respect of buying, holding or selling any securities.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
UPDFZGZDKFLGGZG
Date   Source Headline
29th Nov 202110:53 amRNSDirector/PDMR Shareholding
24th Nov 20212:00 pmRNSDirector/PDMR Shareholding
12th Nov 202110:30 amRNSDirector/PDMR Shareholding
8th Nov 202110:49 amRNSDirector/PDMR Shareholding
4th Nov 20217:05 amRNSResults for the nine months to 30 September 2021
29th Oct 202110:02 amRNSTotal Voting Rights
1st Oct 202112:08 pmRNSTotal Voting Rights
31st Aug 202110:37 amRNSTotal Voting Rights
12th Aug 202110:58 amRNSDirector/PDMR Shareholding
3rd Aug 20212:35 pmRNSDirector/PDMR Shareholding
29th Jul 202110:00 amRNSTotal Voting Rights
28th Jul 20217:00 amRNSInterim results for the six months to 30 June 2021
26th Jul 20217:00 amRNSHolding(s) in Company
22nd Jul 20217:00 amRNSAdditional Listing
15th Jul 20217:00 amRNSAdditional Listing
8th Jul 20217:00 amRNSDirectorate Change
29th Jun 20212:00 pmRNSDirector/PDMR Shareholding
29th Jun 202110:45 amRNSTotal Voting Rights
22nd Jun 20217:00 amRNSCommencement of legal proceedings
16th Jun 20212:00 pmRNSDirector/PDMR Shareholding
15th Jun 202111:06 amRNSDirector/PDMR Shareholding
28th May 20219:30 amRNSTotal Voting Rights
25th May 20211:00 pmRNSResult of AGM
10th May 202111:00 amRNSDirector/PDMR Shareholding
6th May 20217:00 amRNS1st Quarter Results
29th Apr 20219:30 amRNSTotal Voting Rights
21st Apr 20219:30 amRNSNotice of AGM
19th Apr 20217:15 amRNSDeath of Non-Executive Director
6th Apr 20211:45 pmRNSDirector Declaration - Correction
6th Apr 20211:00 pmRNSDirector Declaration
30th Mar 202110:30 amRNSTotal Voting Rights
11th Mar 202111:34 amRNSAnnual Financial Report
3rd Mar 20212:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20219:30 amRNSDirector/PDMR Shareholding
26th Feb 20219:30 amRNSTotal Voting Rights
25th Feb 20216:04 pmRNSIssue of Debt
25th Feb 202110:30 amRNSIssue of Debt
25th Feb 20217:00 amRNSFinal Results
19th Feb 20211:32 pmRNSDirectorate Change
28th Jan 202112:25 pmRNSTotal Voting Rights
28th Jan 20219:00 amRNSDirectorate Change
30th Dec 202010:00 amRNSTotal Voting Rights
29th Dec 20209:00 amRNSHolding(s) in Company
15th Dec 20209:30 amRNSDirector/PDMR Shareholding
10th Dec 202010:00 amRNSHolding(s) in Company
9th Dec 20204:43 pmRNSDirector/PDMR Shareholding - Replacement
9th Dec 20201:30 pmRNSHolding(s) in Company
9th Dec 20201:30 pmRNSDirector/PDMR Shareholding
9th Dec 20201:30 pmRNSHolding(s) in Company
9th Dec 20209:17 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.